Biologics / Biotechnology

#Biologics / Biotechnology #Biotherapeutics #Podcast

Expertise on quantitative analysis of product purity – podcast

In the latest sponsored DDW podcast, discover how accurate and quantitative analysis of product purity is a fundamental for effective development of biotherapeutic proteins. This episode features DDW Editor in Chief  Lu Rahman and Tufan Aydogdu, Field Applications Manager of ProteinSimple, a Bio-Techne brand. Aydogdu talks Lu through how the… Read More

#News

#Biologics / Biotechnology #Biotherapeutics

Bio-Techne further enhances its manufacturing capabilities

Bio-Techne has partnered with Autolomous to implement an electronic batch record system, AutoloMATE, at Bio-Techne’s GMP cellular manufacturing centre. Through this partnership, Bio-Techne will be able to offer electronic records to therapeutic companies utilising its non-viral gene delivery system, TcBuster, or contract cellular manufacturing services alongside working with Autolomous to… Read More

#News

#Antibodies #Awards #Biologics / Biotechnology #Drug development #Oncology #Therapeutics

Matwin spotlights innovation in the fight against cancer

Matwin has picked four companies that will now receive investment from the French oncology accelerator. This was during the MEET2WIN European Oncology Partnering Convention. Step Pharma was awarded ‘First-in-class therapeutic innovation’. The startup’s lead program (STP938) is based on a novel class of oral nucleotide synthesis inhibitors that target CTPS1… Read More

#News

#Biologics / Biotechnology #Cell sequencing #DNA #Drug development #Drug discovery #Genome editing #Genome sequencing #Life sciences #Sequencing #Synthetic biology

The new synthesis: How synthetic DNA technology is changing drug discovery

Listen to this article on the DDW Podcast: Dr Tim Brears, CEO, Evonetix and Dr Raquel Sanches-Kuiper, Director of Biology, Evonetix explore applications of synthetic DNA in drug discovery and development, the benefits and limitations of current methods, and the opportunities offered by emerging DNA synthesis technologies. On 16 April 16,… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#AI #AI / data analytics / healthtech / informatics #Biologics / Biotechnology #Biopharmaceuticals #Drug delivery #Drug development #Drug discovery

Putting the power into drug design: the important role of AI

Valence’s co-founder and CEO, Daniel Cohen, spoke to Lu Rahman about the company’s plan to empower drug discovery scientists with AI-enabled drug design LR:  Outline of the company and its main initiatives DC: Valence is an interdisciplinary team of scientists and engineers out of Mila, the world’s largest deep learning… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#AI / data analytics / healthtech / informatics #Bioentrepreneur #Biologics / Biotechnology #Biotechnology

Tech lets bioentrepreneurs run start-ups from coffee shops

Scispot.io, a life science digitisation and automation company, has launched a digital operating platform for life science leaders and scientists which will allow entrepreneurs to start and virtually run their biotech startups from garages, coffee shops or anywhere innovation is born. The company’s mission is to create a digital life… Read More

#News #Start-up Zone

#Biologics / Biotechnology #Biopharmaceutical #Drug development #Drug discovery #Life sciences

Investment helps establish animal alternative skin testing technology

A near-£1 million investment will help University of Dundee spinout company Ten Bio to commercialise the human skin culture system it developed to provide a viable alternative for many experiments currently performed on animals. The investment will enable the company to progress its mission to transform the testing of new… Read More

#News

Cytometry
#Biologics / Biotechnology #Biotechnology #Drug development #Drug discovery #Flow Cytometry #High throughput screening #Podcast

DDW podcast: Flow cytometry in drug discovery

The latest free to listen to DDW podcast episode, titled Flow Cytometry in Drug Discovery, covers an article written by Urmi Roy for DDW, read aloud by Megan Thomas. This article is called “Why flow cytometry in drug discovery is a real life-saver”, in which Roy, Global Product Manager at… Read More

#News

#Biologics / Biotechnology #Biotechnology #Biotherapeutics #Dementia

Dementia Discovery Fund enhances its neuroscience R&D expertise

The Dementia Discovery Fund (DDF), the venture capital fund investing in, and creating, biotech companies pursuing transformational therapeutic approaches for dementias, has announced the appointments of Dr Lynne Hughes and Dr James Summers as Venture Partners, bringing additional expertise in neuroscience research and development. Dr Jonathan Behr, Partner at The… Read More

#News

#Assays #Biologics / Biotechnology #Covid-19 #Data

GSK and Vir Biotechnology request for EUA for COVID-19 treatment

GlaxoSmithKline (GSK) and Vir Biotechnology have announced the submission of an application to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorisation (EUA) for VIR-7831 (GSK4182136), an investigational dual-action SARS-CoV-2 monoclonal antibody, for the treatment of adults and adolescents (aged 12 years and older weighing at least 40… Read More

#Covid-19 #News

#Biologics / Biotechnology #Biotechnology #iPSC

Axol Bioscience and Censo Biotechnologies announce merger

Axol Bioscience, provider of iPSC-derived cells, media, and characterisation services, and CENSO Biotechnologies, a cell biology CRO with focused expertise in iPSC-related technologies,  have signed a merger agreement. The new entity will become a provider of product and service solutions in the iPSC-based neuroscience, immune cell, and cardiac modelling for… Read More

#News

#Biologics / Biotechnology #Drug development #Events #Exhibition

SLAS Europe 2021 registration now open

Registration is now open for the SLAS Europe 2021 Hybrid Conference and Exhibition, which aims to connect people and advance science. There are flexible rates and registration options for both the in-person events in Vienna and Austria, and online, from June 22-25, 2021. SLAS Europe 2021 Hybrid offers a programme… Read More

#News

#Biologics / Biotechnology #Biotherapeutics #Cancer immunotherapy #Drug discovery

Bicara Therapeutics launches biologics for cancer immunotherapy

Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics designed to spur a potent and durable immune response in the tumour microenvironment, launched with a US$40 million investment from Biocon. The financing will be used to advance a pipeline of first-in-class bifunctional antibodies developed by a global team, including a… Read More

#Cancer Research #News

#Biologics / Biotechnology #Cancer immunotherapy #Cancer research #Drug development

Pathios Therapeutics boosted with Innovate UK funding

Pathios, a biotech company focused on the development of first-in-class therapies for cancer, announced that it has been awarded £350K in the form of a Smart Grant from Innovate UK. The UK government innovation agency’s money will accelerate Pathios’ cancer immunotherapy programme which targets the innate immune checkpoint, GPR65. Pathios… Read More

#Cancer Research #News

#Antibodies #Biologics #Biologics / Biotechnology #Cell therapy

IONTAs and FairJourney antibody agreement with Quell Therapeutics

IONTAS and FairJourney Biologics (FJB) have entered into an agreement with Quell Therapeutics regarding IONTAS / FJB’s proprietary libraries and technology platforms. A diverse panel of novel target binders from IONTAS and FairJourney Biologics (FJB) will be used to identify antibodies to advance Quell’s engineered Treg cell therapy pipeline. Quell… Read More

#News #Trending News

#Biologics / Biotechnology #Clinical trials #Oncology

The importance of partnership and innovation in oncology

Fostering synergies to accelerate innovation in oncology and make it attractive for partners has been the MATWIN motto for over a decade, writes CEO Lucia Robert, MATWIN who outlines the organisations’s work MATWIN is a French open-innovation platform dedicated to supporting innovation in oncology. For more than ten years, its… Read More

#Cancer Research #Exclusive Content #News